UniProt ID | CHM2A_HUMAN | |
---|---|---|
UniProt AC | O43633 | |
Protein Name | Charged multivesicular body protein 2a | |
Gene Name | CHMP2A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 222 | |
Subcellular Localization |
Late endosome membrane Peripheral membrane protein Cytoplasmic side . Localizes to the midbody of dividing cells. Localized in two distinct rings on either side of the Fleming body. |
|
Protein Description | Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis. [PubMed: 21310966 Together with SPAST, the ESCRT-III complex promotes nuclear envelope sealing and mitotic spindle disassembly during late anaphase] | |
Protein Sequence | MDLLFGRRKTPEELLRQNQRALNRAMRELDRERQKLETQEKKIIADIKKMAKQGQMDAVRIMAKDLVRTRRYVRKFVLMRANIQAVSLKIQTLKSNNSMAQAMKGVTKAMGTMNRQLKLPQIQKIMMEFERQAEIMDMKEEMMNDAIDDAMGDEEDEEESDAVVSQVLDELGLSLTDELSNLPSTGGSLSVAAGGKKAEAAASALADADADLEERLKNLRRD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDLLFGRR -------CCCCCCCC | 8.06 | 12665801 | |
9 | Ubiquitination | DLLFGRRKTPEELLR CCCCCCCCCHHHHHH | 68.05 | - | |
10 | Phosphorylation | LLFGRRKTPEELLRQ CCCCCCCCHHHHHHH | 33.84 | 21815630 | |
38 | Phosphorylation | RERQKLETQEKKIIA HHHHHHHHHHHHHHH | 53.09 | 20068231 | |
48 | Ubiquitination | KKIIADIKKMAKQGQ HHHHHHHHHHHHCCC | 36.72 | 21890473 | |
52 | Acetylation | ADIKKMAKQGQMDAV HHHHHHHHCCCCHHH | 52.00 | 12435057 | |
52 | Ubiquitination | ADIKKMAKQGQMDAV HHHHHHHHCCCCHHH | 52.00 | 21906983 | |
64 | Ubiquitination | DAVRIMAKDLVRTRR HHHHHHHHHHHHHHH | 33.93 | 21906983 | |
87 | Phosphorylation | RANIQAVSLKIQTLK HCHHHHHHHHHHHHH | 27.28 | 28857561 | |
89 | Acetylation | NIQAVSLKIQTLKSN HHHHHHHHHHHHHCC | 25.84 | 25953088 | |
89 | Ubiquitination | NIQAVSLKIQTLKSN HHHHHHHHHHHHHCC | 25.84 | 21906983 | |
92 | Phosphorylation | AVSLKIQTLKSNNSM HHHHHHHHHHCCCHH | 39.36 | - | |
94 | Ubiquitination | SLKIQTLKSNNSMAQ HHHHHHHHCCCHHHH | 55.30 | 21906983 | |
94 | Acetylation | SLKIQTLKSNNSMAQ HHHHHHHHCCCHHHH | 55.30 | 27452117 | |
95 | Phosphorylation | LKIQTLKSNNSMAQA HHHHHHHCCCHHHHH | 44.34 | 25159151 | |
98 | Phosphorylation | QTLKSNNSMAQAMKG HHHHCCCHHHHHHHH | 21.53 | 28857561 | |
104 | Ubiquitination | NSMAQAMKGVTKAMG CHHHHHHHHHHHHHH | 53.93 | 21906983 | |
108 | Ubiquitination | QAMKGVTKAMGTMNR HHHHHHHHHHHHHHH | 33.69 | 21906983 | |
118 | Ubiquitination | GTMNRQLKLPQIQKI HHHHHHCCCHHHHHH | 50.19 | 21906983 | |
118 | Acetylation | GTMNRQLKLPQIQKI HHHHHHCCCHHHHHH | 50.19 | 25038526 | |
124 | Ubiquitination | LKLPQIQKIMMEFER CCCHHHHHHHHHHHH | 33.91 | 21906983 | |
124 | Acetylation | LKLPQIQKIMMEFER CCCHHHHHHHHHHHH | 33.91 | 25038526 | |
126 | Sulfoxidation | LPQIQKIMMEFERQA CHHHHHHHHHHHHHH | 2.44 | 21406390 | |
174 | Phosphorylation | VLDELGLSLTDELSN HHHHHCCCCCHHHHC | 27.68 | 24275569 | |
180 | Phosphorylation | LSLTDELSNLPSTGG CCCCHHHHCCCCCCC | 33.98 | 24275569 | |
184 | Phosphorylation | DELSNLPSTGGSLSV HHHHCCCCCCCCCEE | 42.73 | 29759185 | |
185 | Phosphorylation | ELSNLPSTGGSLSVA HHHCCCCCCCCCEEC | 43.55 | 29759185 | |
188 | Phosphorylation | NLPSTGGSLSVAAGG CCCCCCCCCEECCCC | 20.86 | 29759185 | |
190 | Phosphorylation | PSTGGSLSVAAGGKK CCCCCCCEECCCCHH | 16.06 | 29759185 | |
197 | Ubiquitination | SVAAGGKKAEAAASA EECCCCHHHHHHHHH | 55.52 | 21906983 | |
203 | Phosphorylation | KKAEAAASALADADA HHHHHHHHHHHHCCC | 21.06 | 22617229 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CHM2A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CHM2A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CHM2A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
STABP_HUMAN | STAMBP | physical | 17159328 | |
CHMP3_HUMAN | CHMP3 | physical | 17159328 | |
VPS4A_HUMAN | VPS4A | physical | 16730941 | |
CHM2A_HUMAN | CHMP2A | physical | 16730941 | |
CHMP3_HUMAN | CHMP3 | physical | 16730941 | |
NOL4_HUMAN | NOL4 | physical | 16730941 | |
EI2BE_HUMAN | EIF2B5 | physical | 16730941 | |
MITD1_HUMAN | MITD1 | physical | 16730941 | |
RBP2_HUMAN | RANBP2 | physical | 22939629 | |
ERLN1_HUMAN | ERLIN1 | physical | 22939629 | |
PP1A_HUMAN | PPP1CA | physical | 22939629 | |
RRBP1_HUMAN | RRBP1 | physical | 22939629 | |
E2F4_HUMAN | E2F4 | physical | 21988832 | |
TGFB3_HUMAN | TGFB3 | physical | 21988832 | |
DOCK8_HUMAN | DOCK8 | physical | 25416956 | |
4EBP1_HUMAN | EIF4EBP1 | physical | 26344197 | |
PARVA_HUMAN | PARVA | physical | 26344197 | |
TRI35_HUMAN | TRIM35 | physical | 28514442 | |
VTA1_HUMAN | VTA1 | physical | 28514442 | |
DECR_HUMAN | DECR1 | physical | 28514442 | |
CHMP5_HUMAN | CHMP5 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 1-7, AND ACETYLATION AT MET-1. | |
Phosphorylation | |
Reference | PubMed |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203, AND MASSSPECTROMETRY. |